[A case of successful multimodal treatment for combined hepatocellular and cholangiocarcinoma with portal venous tumor thrombus]
- PMID: 20037427
[A case of successful multimodal treatment for combined hepatocellular and cholangiocarcinoma with portal venous tumor thrombus]
Abstract
We report a case of successful multimodal treatment for combined hepatocellular and cholangiocarcinoma with portal venous tumor thrombus. A 66-year-old man was diagnosed with hepatocellular carcinoma with Vp3 by abdominal enhanced CT. He underwent a complete tumor resection and following interferon and 5-FU combined intra-arterial chemotherapy as an adjuvant setting. The histological findings were consistent with combined hepatocellular and cholangiocarcinoma. At 9 months after the surgery, lymph node metastases were detected. Then we started an oral fluoropyrimidine anticancer agent S-1, because the recurrence was suspected to be originated from the cholangiocarcinoma component. Thereafter, sustained partial remission was achieved. In case of combined hepatocellular and cholangiocarcinoma, we need to create a treatment strategy against characteristics of both components.
Similar articles
-
[A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha].Gan To Kagaku Ryoho. 2005 Oct;32(11):1824-8. Gan To Kagaku Ryoho. 2005. PMID: 16315953 Japanese.
-
[A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy].Gan To Kagaku Ryoho. 2006 Nov;33(12):1941-3. Gan To Kagaku Ryoho. 2006. PMID: 17212153 Japanese.
-
[A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT].Gan To Kagaku Ryoho. 2009 Nov;36(12):2380-2. Gan To Kagaku Ryoho. 2009. PMID: 20037429 Japanese.
-
Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients.Hepatogastroenterology. 1998 Mar-Apr;45(20):523-7. Hepatogastroenterology. 1998. PMID: 9638442 Review.
-
[A successful case of systemic chemotherapy followed by liver resection for advanced hepatocellular carcinoma with highly vascular invasion and multiple pulmonary metastases].Gan To Kagaku Ryoho. 2011 May;38(5):849-52. Gan To Kagaku Ryoho. 2011. PMID: 21566452 Review. Japanese.
Cited by
-
Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management.Liver Cancer. 2023 Apr 24;13(1):6-28. doi: 10.1159/000530700. eCollection 2024 Feb. Liver Cancer. 2023. PMID: 38344449 Free PMC article. Review.
-
Management of Locally Advanced or Metastatic Combined Hepatocellular Cholangiocarcinoma.Cancers (Basel). 2023 Feb 3;15(3):988. doi: 10.3390/cancers15030988. Cancers (Basel). 2023. PMID: 36765942 Free PMC article. Review.
-
Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma.Cancer Sci. 2018 Aug;109(8):2549-2557. doi: 10.1111/cas.13656. Epub 2018 Jun 27. Cancer Sci. 2018. PMID: 29856900 Free PMC article.
-
Elevated levels of mRNAs encoding dihydropyrimidine dehydrogenase and thymidylate synthase are associated with improved survival of patients with hepatocellular carcinoma treated with S-1.Oncol Lett. 2017 Jul;14(1):930-936. doi: 10.3892/ol.2017.6241. Epub 2017 May 24. Oncol Lett. 2017. PMID: 28693254 Free PMC article.
-
Treatment of Combined Hepatocellular and Cholangiocarcinoma.Cancers (Basel). 2020 Mar 26;12(4):794. doi: 10.3390/cancers12040794. Cancers (Basel). 2020. PMID: 32224916 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical